3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
18
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
14
Carcinoma, Hepatocellular
5
Liver Neoplasms
3
Gastrointestinal Stromal Tumors
2
TAS 102
1
Neoplasms
1
Neoplasm Metastasis
1
Metastatic Colorectal Adenocarcinoma
1
Glioblastoma
1
Colonic Neoplasms
1
COVID-19
1
Advanced Gastrointestinal Stromal Tumor
1
Advanced Colorectal Carcinoma
1
Interventions
Blood Specimen Collection
7
Drug Therapy
6
Surveys and Questionnaires
5
Radiotherapy
5
Radiosurgery
5
Docetaxel
5
Therapeutics
4
Specimen Handling
4
Immunotherapy
4
Hepatectomy
4
exemestane
3
enzalutamide
3
apalutamide
3
Trastuzumab
3
Hematologic Tests
3
Data Collection
3
Biopsy
3
Biological Assay
3
Anastrozole
3
Abiraterone Acetate
3
trastuzumab deruxtecan
2
palbociclib
2
darolutamide
2
abiraterone
2
abemaciclib
2
Wearable Electronic Devices
2
Triptorelin Pamoate
2
Tamoxifen
2
Surgical Procedures, Operative
2
Radiotherapy, Intensity-Modulated
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Neoplasm Metastasis
×
regorafenib
×
Clear all
NCT02106858
2023-07-24
StivargaPMS
Bayer
Completed
316 enrolled